BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 68718)

  • 1. Effect of O-(beta-hydroxyethyl)-rutoside on the glucose metabolism of cultured human varicose saphenous veins.
    Matagne D; Gilles R
    Arch Int Physiol Biochim; 1977 Feb; 85(1):133-8. PubMed ID: 68718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of O-(beta-hydroxyethyl)-rutoside or venoruton on lactate dehydrogenase of human cultured varicose veins.
    Matagne D; Hamoir G
    Biochem Pharmacol; 1975 Aug; 24(16):1491-4. PubMed ID: 1191306
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of large doses of a flavonoid O-(betahydroxyethyl)-rutoside on some aspects of venous circulation].
    Forconi S; Guerrini M
    Clin Ter; 1977 Feb; 80(3):229-55. PubMed ID: 852233
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of the activity of a flavonoid, 3-(beta-hydroxyethyl)-rutoside, at high dose levels on venous tone measured by "strain gauge" plethylsmography.
    Forconi S; Guerrini M; Di Perri T
    Vasa; 1977; 6(3):279-84. PubMed ID: 335696
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modifications induced by long-term treatment with high doses of 0-(beta-hydroxyethyl)-rutoside in chronic venous insufficiency].
    Barbarino C; Pezzangora V
    Vasa Suppl; 1989; 27():120. PubMed ID: 2623482
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of O-(beta-hydroxyethyl)-rutoside on wound healing in the rat.
    Wilhelmi G
    Pharmacology; 1979; 19(2):82-5. PubMed ID: 531085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of o-(beta-hydroxyethyl)-rutoside in lymphangiography.
    Broks PD
    AJR Am J Roentgenol; 1977 Feb; 128(2):263-5. PubMed ID: 401613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some aspects of the metabolism of the wall of the normal and varicose human saphenous vein].
    NANTE L; SERRA GC
    Sperimentale; 1961; 111():325-32. PubMed ID: 14478326
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of tri- and tetra-O-(beta-hydroxyethyl)-rutoside on red blood cell aggregation of human blood.
    van Haeringen NJ
    Bibl Anat; 1975; 13():197-9. PubMed ID: 1231726
    [No Abstract]   [Full Text] [Related]  

  • 10. The flavonoid 7-mono-O-(β-hydroxyethyl)-rutoside is able to protect endothelial cells by a direct antioxidant effect.
    Lemmens KJ; van de Wier B; Vaes N; Ghosh M; van Zandvoort MA; van der Vijgh WJ; Bast A; Haenen GR
    Toxicol In Vitro; 2014 Jun; 28(4):538-43. PubMed ID: 24412621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of O-(beta-hydroxyethyl)-rutoside (HR) on macromolecular leakage, thrombosis and haemostasis in experimental animals.
    Bergqvist D; Svensjö E; Arfors KE
    Ups J Med Sci; 1978; 83(2):123-7. PubMed ID: 664118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulated apoptosis of the venous wall in chronic venous disease and portal hypertension.
    Kun L; Ying L; Lei W; Jianhua Z; Yongbo X; Tao W; Jinyuan T; Haibo C
    Phlebology; 2016 Dec; 31(10):729-736. PubMed ID: 26447135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pentoxifylline administered in vivo on the synthesis of PGI2 in human varicose veins.
    Fahr A; Langer R; Sziegoleit W; Albert H; Liebal H; Mest HJ
    Biomed Biochim Acta; 1988; 47(10-11):S238-40. PubMed ID: 3073763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of O-(beta-hydroxyethyl)-rutoside (venoruton) on the adherence of leukocytes in patients with arteriosclerosis obliterans of the lower limbs].
    Lukjan H; Szpak A; Bodzenta A; Bielawiec M; Rosc D; Chyzy R
    Pol Arch Med Wewn; 1985 Jun; 73(6):345-50. PubMed ID: 3880372
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of two venotropic drugs on inactivation and O-methylation of catecholamines in an isolated canine vein.
    Araújo D; Gulati O; Osswald W
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):192-202. PubMed ID: 4062437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen of the normal and the varicose human saphenous vein: a biochemical study.
    Maurel E; Azema C; Deloly J; Bouissou H
    Clin Chim Acta; 1990 Dec; 193(1-2):27-37. PubMed ID: 2073743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional activity of varicose human great saphenous vein at different sites.
    Ziganshin BA; Slavin DA; Ziganshina AP; Dzhordzhikiya RK; Ziganshin AU
    Bull Exp Biol Med; 2013 Aug; 155(4):429-32. PubMed ID: 24298651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and localisation of O-(beta-hydroxyethyl)-rutosides in the venous wall, measured by laser scanning microscopy.
    Neumann HA; Carlsson K; Brom GH
    Eur J Clin Pharmacol; 1992; 43(4):423-6. PubMed ID: 1451724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the effects of betabeta'-iminodipropionitrile and O-(beta-hydroxyethyl)-rutoside on ADP-activated aggregation of rat platelets in relation to the development of diabetic microangiopathy.
    Pollock J; Heath H
    Biochem Pharmacol; 1975 Feb; 24(3):397-400. PubMed ID: 1125047
    [No Abstract]   [Full Text] [Related]  

  • 20. Diosmin therapy alters the in vitro metabolism of noradrenaline by the varicose human saphenous vein.
    Araujo D; Viana F; Osswald W
    Pharmacol Res; 1991 Oct; 24(3):253-6. PubMed ID: 1956869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.